Sean Dodge
Stock Analyst at RBC Capital
(2.02)
# 2,858
Out of 4,873 analysts
133
Total ratings
31.96%
Success rate
-3.63%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $3.75 | +60.21% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $2.21 | +58.37% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $158.58 | +70.26% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $8.00 | +50.00% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $148.54 | +77.06% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $10.62 | +60.08% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $27.87 | +14.82% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $12.97 | -53.74% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $104.18 | +0.79% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $11.24 | +51.25% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $38.70 | -12.14% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $22.96 | -39.02% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $5.07 | +97.24% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $22.00 | +27.27% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $14.52 | -3.58% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $172.05 | -80.82% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $1.05 | +17,042.86% | 2 | Mar 9, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $3.75
Upside: +60.21%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $2.21
Upside: +58.37%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $158.58
Upside: +70.26%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $8.00
Upside: +50.00%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $148.54
Upside: +77.06%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $10.62
Upside: +60.08%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $27.87
Upside: +14.82%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $12.97
Upside: -53.74%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $104.18
Upside: +0.79%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $11.24
Upside: +51.25%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $38.70
Upside: -12.14%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $22.96
Upside: -39.02%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $5.07
Upside: +97.24%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $22.00
Upside: +27.27%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $14.52
Upside: -3.58%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $172.05
Upside: -80.82%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $1.05
Upside: +17,042.86%